Resources

266 Resources for

tablet

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Speak with other shareholders about: (OTCBB: WWAT), (Nasdaq: CRTX), (OTCBB: ICPR), (OTCBB: DHNA), (PINK SHEETS: HMIT).
M2 PRESSWIRE-31 May 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: WWAT), (Nasdaq: CRTX), (OTCBB: ICPR), (OTCBB: DHNA), (PINK SHEETS: HMIT)C1994-2007 M2 COMMUNICATIONS LTD RDATE:31052007 AUSTIN, TX - Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked...
Tags: asthma, Company, compensation, FINANCE, investor, Nasdaq Stock Market Inc., patient, Sam, shareholder, stock, tablet
Research articles 2007-05-31
Best Sales Tool: Smartphone or Notebook?
Best Sales Tool: Smartphone or Notebook?Smartphone or Notebook?I don't think smartphones are up to the task for someone who must stay "connected." The issue -- screen size. (Sorry to hear about the stewardess's comment, Geoffrey. I feel your pain.)I'm a technology junkie (gadgets, hardware and software, too)....
Tags: smart phone, e-mail, notebook, sales, sales tool, Smartphone, tablet, tablet PC
Discussion threads 2008-06-18
Seniors, Disabled in Medicare's Coverage 'Donut Hole' Should Talk to Doctor about Switching to Cost-Effective Drugs ; Switching Could Save Hundreds a Month; Help Ensure They Still Get Needed Medicines
WASHINGTON, Sept. 20 /U.S. Newswire/ -- As millions of seniors and disabled fall into the Medicare Part D "donut hole" coverage gap in coming weeks, Consumer Reports Best Buy Drugs urges beneficiaries to talk to their doctor about switching to cost- effective medications that will dramatically cut their out-of- pocket...
Tags: beneficiary, Best Buy Co. Inc., Consumer Reports, HEALTHCARE, Medicare, prescription, tablet
Research articles 2006-09-20
New Once-Daily Oral Diabetes Treatment Glumetza™ Now Available
BRISTOL, Tenn. & MENLO PARK, Calif. -- - Novel Drug-Delivery Technology Enables Extended-Release Formulation to Combine Efficacy Benefits of Metformin with Once-Daily Dosing to Maximize Metformin Therapy - Adult patients living with type 2 diabetes now have a new treatment option available that may help them get the...
Tags: American Diabetes Association, benefit, dependence, patient, tablet, U.S.
Research articles 2006-09-06
Nokia.(WHAT ENGINEERS WANT)(Brief article)
Nokia's N800 series electronic tablet provides Internet access, instant messaging, e-mail, and Internet calling with optional video camera. The tablet is equipped with a high-resolution widescreen display, high-quality audio speakers and microphone, Nokia's N800 series electronic tablet provides Internet access, instant messaging, e-mail, and...
Tags: Nokia Corp., tablet, video
Research articles 2007-10-01
Depomed and King Pharmaceuticals Prepare for Launch of Glumetza™ as Timely, New ADA Guidelines Are Issued; Consensus Statement Recommends That Metformin Be Added to Lifestyle Changes as Initial Treatment for Type 2 Diabetes
MENLO PARK, Calif. & BRISTOL, Tenn. -- Depomed, Inc. (NASDAQ:DEPO) and King Pharmaceuticals, Inc. (NYSE:KG) announced today that as they prepare for the launch of GlumetzaTM (metformin hydrochloride extended-release tablets), a new consensus statement was issued from the American Diabetes Association ADA and the European Association for the Study of...
Tags: American Diabetes Association, DepoMed Inc., diagnosis, patient, tablet
Research articles 2006-08-23
Bloodstain reagent.(Forensics Showcase)
A compact and lightweight multi-use product, each pack of BLUESTAR Forensic Tablets enables an investigator to prepare 4 ounces of BLUESTAR FORENSIC working solution eight times or up to 1 liter (32 ounces) if all tablets are used together. Each pack A compact and lightweight multi-use...
Tags: BlueStar, tablet
Research articles 2007-04-01
Visa and Tablet Hotels to Offer Elite Hotel Privileges at Exclusive Hotels Worldwide
Tablet Plus Members Only Program Gives Select Visa Signature Cardholders Expanded Amenities at More Than 100 Tablet Hotels
Tags: tablet, Visa Inc.
Research articles 2007-10-26
Lupin Pharmaceuticals Inc. gets FDA go-ahead
Lupin Pharmaceuticals Inc., an Indian company whose sales and marketing headquarters is in Baltimore, said it received permission from the Food and Drug Administration to market Amlodipine Beylate tablets, a generic drug used to treat high blood pressure. Commercial shipments of tablets in 2.5 milligram, 5 mg and 10 mg...
Tags: FDA, tablet
Research articles 2007-07-19
CDW-G Provides Fujitsu Tablets to Incoming Cadets at U.S. Air Force Academy
Tablet Computers Selected After Rigorous Procurement Process, Meeting the Unique Needs of Future Air Force Officers
Tags: Fujitsu Ltd., tablet
Research articles 2007-08-07
TEVA announces approval of Clarithromycin ER tablets, Pharmion Corporation to present at UBS Global Pharmaceuticals Conference.
M2 PRESSWIRE-19 May 2005-US Financial Network: TEVA announces approval of Clarithromycin ER tablets, Pharmion Corporation to present at UBS Global Pharmaceuticals ConferenceC1994-2005 M2 COMMUNICATIONS LTD RDATE:19052005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC:...
Tags: FINANCE, financial, Nasdaq Stock Market Inc., Pharmion Corp., stem-cell, tablet, TEVA, UBS AG
Research articles 2005-05-19
Teva announces tentative approval of olanzapine tablets and Immunomedics' humanized anti-CD20 antibody effective in severe lupus.
M2 PRESSWIRE-29 March 2005-US Financial Network: Teva announces tentative approval of olanzapine tablets and Immunomedics' humanized anti-CD20 antibody effective in severe lupusC1994-2005 M2 COMMUNICATIONS LTD RDATE:29032005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC:...
Tags: FINANCE, financial, Nasdaq Stock Market Inc., tablet, Teva
Research articles 2005-03-29
Baltimore-based Lupin drug receives OK from FDA
Lupin Pharmaceuticals Inc., of Baltimore, the U.S. subsidiary of an Indian pharmaceutical manufacturer, said it received Food and Drug Administration approval of its application to market simvastatin tablets in 10, 20, 40 and 80 milligram doses. Lupin said its simvastatin tablets are the generic equivalent of Merck & Co.'s Zocor...
Tags: FDA, tablet
Research articles 2007-05-16
Desperate for headache tablets, man holds up pharmacy in Sweden
STOCKHOLM AFP — A man brandishing a gun-like object held up a drugstore in the small southwestern Swedish town of Bollebygd and made off with his booty: a package of headache tablets, Swedish media reported. The man walked into the pharmacy, pulled out an object that resembled a gun...
Tags: Agence France-Presse, Branding, Handhelds, HARDWARE, MARKETING, pharmacy, tablet
Research articles 2004-12-20
IVAX to Begin Sale of Morphine Sulfate Controlled-Release Tablets C-II as Authorized Distributor
MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that its U.S. generic subsidiary, IVAX Pharmaceuticals, Inc., will distribute, in the United States, morphine sulfate controlled-release tablets C-II in 15, 30, 60, 100 and 200 mg dosage strengths supplied by Purdue Pharma LP of Stamford, Connecticut. Morphine sulfate controlled-release tablets...
Tags: IVAX Corp., tablet
Research articles 2005-07-29
AuthenTec Adds Security to New Motion Computing Tablet PC
New F5 Tablet is Motion's First Semi-Rugged, Fingerprint-Enabled Tablet PC Tailored for Today's Mobile Field Worker
Tags: PC, security, tablet, tablet PC
Research articles 2008-05-05
IVAX Receives Final Approval for Doxycycline Hyclate Tablets
MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for doxycycline hyclate 20 mg tablets. This product will be sold through IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc. Doxycycline hyclate 20 mg tablets...
Tags: IVAX Corp., tablet
Research articles 2005-05-13
Depomed Files Prior Approval Supplement for 1000 mg Strength Tablets of Glumetza
MENLO PARK, Calif. -- Depomed, Inc. (NASDAQ:DEPO) announced today that it has filed a prior approval supplement with the U.S. Food and Drug Administration FDA seeking approval to market in the United States 1000 mg strength tablets of GlumetzaTMmetformin hydrochloride extended release tablets. The company expects the FDA to make...
Tags: FDA, tablet
Research articles 2007-04-02
UPEK Provides Biometric Fingerprint Security for the ThinkPad Tablet; Lenovo Expands Integration of UPEK Technology Across Notebook PC Product Line With Introduction of ThinkPad X41 Tablet
BERKELEY, Calif. -- UPEKR, Inc., the leading supplier of biometric fingerprint security solutions, today announced that Lenovo has chosen UPEK's fingerprint authentication solutions to secure their ThinkPad* Series of notebooks with the introduction of the new ThinkPad X41 Tablet. Lenovo incorporated UPEK technology on select models of the ThinkPad X41...
Tags: IBM ThinkPad, Lenovo Group Ltd., notebook, notebook computer, tablet
Research articles 2005-07-25
WATSON PHARMACEUTICALS Inc.(Brief Article)
WATSON PHARMACEUTICALS Inc.'s abbreviated new drug application for oxycodone and acetaminophen tablets has been approved by FDA. The tablets are USP, 7.5 ... WATSON PHARMACEUTICALS Inc.'s abbreviated new drug application for oxycodone and acetaminophen tablets has been approved by FDA. The tablets are...
Tags: tablet
Research articles 2001-01-08
advertisement
advertisement